Mary Cohen-Williams

1.2k citations

28 papers · 892 indexed · h-index 17

Cellular and Molecular Neuroscience top 5%
Molecular Biology
Physiology top 2%
Physiology
Organic Chemistry

Co-authors: Geoffrey B. Varty Vicki L. Coffin John C. Hunter Galen Carey Jean E. Lachowicz Robert A. Hodgson Guy A. Higgins Timothy J. Kowalski
Topics: Receptor Mechanisms and Signaling (11 papers)Neuroscience and Neuropharmacology Research (7 papers)Adenosine and Purinergic Signaling (7 papers)
Cited by: Physiology Cellular and Molecular Neuroscience Endocrine and Autonomic Systems
Journals: Brain Research Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States Bulgaria Switzerland

In The Last Decade

Mary Cohen-Williams

28 papers receiving 844 citations

Peers

Countries citing papers authored by Mary Cohen-Williams

Since Specialization

Citations

This map shows the geographic impact of Mary Cohen-Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Cohen-Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Cohen-Williams more than expected).

Fields of papers citing papers by Mary Cohen-Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Cohen-Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Cohen-Williams. The network helps show where Mary Cohen-Williams may publish in the future.

Co-authorship network of co-authors of Mary Cohen-Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Cohen-Williams. A scholar is included among the top collaborators of Mary Cohen-Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Cohen-Williams. Mary Cohen-Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design and synthesis of water soluble β-aminosulfone analogues of SCH 900229 as γ-secretase inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Wen‐Lian Wu,Duane A. Burnett,John W. Clader,William J. Greenlee,Qin Jiang,Lynn A. Hyde,Robert A. Del Vecchio,Mary Cohen-Williams,Lixin Song,Julie Lee,Giuseppe Terracina,Qi Zhang,Amin A. Nomeir,Eric M. Parker,Lili Zhang	2
2	Discovery of a Potent Pyrazolopyridine Series of γ-Secretase Modulators 2011 ·ACS Medicinal Chemistry Letters ·Jun Qin,Wei Zhou,Xianhai Huang,(unknown),Anandan Palani,Robert Aslanian,Zhaoning Zhu,William J. Greenlee,Mary Cohen-Williams,Nicholas A. Jones,Lynn A. Hyde,Lili Zhang	22
3	Characterization of the selective mGluR1 antagonist, JNJ16259685, in rodent models of movement and coordination 2010 ·Pharmacology Biochemistry and Behavior ·Robert A. Hodgson,Lynn A. Hyde,(unknown),Mary Cohen-Williams,Prescott T. Leach,Tatiana M. Kazdoba,(unknown),Sherry Lu,Eric M. Parker,Geoffrey B. Varty	13
4	Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators 2010 ·Bioorganic & Medicinal Chemistry Letters ·Jun Qin,(unknown),Xianhai Huang,Mihirbaran Mandal,Zhiqiang Zhao,Dmitri Pissarnitski,Wei Zhou,Robert Aslanian,Zhaoning Zhu,William J. Greenlee,John W. Clader,Lili Zhang,Mary Cohen-Williams,Nicholas A. Jones,Lynn A. Hyde,Anandan Palani	19
5	Iminoheterocycles as γ-secretase modulators 2010 ·Bioorganic & Medicinal Chemistry Letters ·John P. Caldwell,(unknown),(unknown),Robert Mazzola,Thomas Bara,Alexei V. Buevich,Duane A. Burnett,Inhou Chu,Mary Cohen-Williams,(unknown),Lynn A. Hyde,Julie Lee,(unknown),Lixin Song,Giuseppe Terracina,Johannes Voigt,Lili Zhang,Zhaoning Zhu	19
6	Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and Depression 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Robert A. Hodgson,Rosalia Bertorelli,Geoffrey B. Varty,Jean E. Lachowicz,A Forlani,Silva Fredduzzi,Mary Cohen-Williams,Guy A. Higgins,Francesco Impagnatiello,(unknown),Leonard E. Parra,Carolyn Foster,Ying Zhai,(unknown),Andrew W. Stamford,Eric M. Parker,Angelo Reggiani,John C. Hunter	128
7	The Anxiolytic-Like Effects of the Novel, Orally Active Nociceptin Opioid Receptor Agonist 8-[bis(2-Methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510) 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Geoffrey B. Varty,Sherry Lu,Cynthia A. Morgan,Mary Cohen-Williams,Robert A. Hodgson,April Smith‐Torhan,Hongtao Zhang,Ahmad Fawzi,Michael P. Graziano,Ginny D. Ho,Julius J. Matasi,Deen Tulshian,Vicki L. Coffin,Galen Carey	67
8	Potent and selective adenosine A2A receptor antagonists: 1,2,4-Triazolo[1,5-c]pyrimidines 2008 ·Bioorganic & Medicinal Chemistry Letters ·Bernard R. Neustadt,Hong Liu,Jinsong Hao,William J. Greenlee,Andrew W. Stamford,Carolyn Foster,Leyla Arik,Jean E. Lachowicz,Hongtao Zhang,Rosalia Bertorelli,Silva Fredduzzi,Geoffrey B. Varty,Mary Cohen-Williams,Kwokei Ng	34
9	Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Samuel Chackalamannil,William J. Greenlee,Bernard R. Neustadt,Mary Cohen-Williams,Guy A. Higgins,Kwokei Ng,Geoffrey B. Varty,Hongtao Zhang,Jean E. Lachowicz	16
10	2‐(2‐Furanyl)‐7‐phenyl[1,2,4]triazolo[1,5‐c]pyrimidin‐5‐amine Analogues: Highly Potent, Orally Active, Adenosine A_2A Antagonists. Part 1. 2006 ·ChemInform ·Julius J. Matasi,John P. Caldwell,Hongtao Zhang,Ahmad Fawzi,Mary Cohen-Williams,Geoffrey B. Varty,Deen Tulshian	3
11	2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: The successful reduction of hERG activity. Part 2 2005 ·Bioorganic & Medicinal Chemistry Letters ·Julius J. Matasi,John P. Caldwell,Hongtao Zhang,Ahmad Fawzi,Guy A. Higgins,Mary Cohen-Williams,Geoffrey B. Varty,Deen Tulshian	15
12	2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs: Highly potent, orally active, adenosine A2A antagonists. Part 1 2005 ·Bioorganic & Medicinal Chemistry Letters ·Julius J. Matasi,John P. Caldwell,Hongtao Zhang,Ahmad Fawzi,Mary Cohen-Williams,Geoffrey B. Varty,Deen Tulshian	15
13	Melanin-concentrating hormone-1 receptor antagonism decreases feeding by reducing meal size 2004 ·European Journal of Pharmacology ·Timothy J. Kowalski,Constance Farley,Mary Cohen-Williams,Geoffrey B. Varty,Brian D. Spar	68
14	The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test 2003 ·Behavioural Pharmacology ·Geoffrey B. Varty,Mary Cohen-Williams,John C. Hunter	59
15	Comparison of apomorphine, amphetamine and dizocilpine disruptions of prepulse inhibition in inbred and outbred mice strains 2001 ·European Journal of Pharmacology ·Geoffrey B. Varty,(unknown),Mary Cohen-Williams,Galen Carey	58
16	SCH 57790, a selective muscarinic M2 receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals 2001 ·European Journal of Pharmacology ·Galen Carey,William Billard,Herbert Binch,Mary Cohen-Williams,Gordon Crosby,Michael Grzelak,Henry Guzik,Joseph A. Kozlowski,Derek Lowe,Annamarie J. Pond,(unknown),Robert W. Watkins,Vicki L. Coffin	59
17	Facilitation of acetylcholine release and improvement in cognition by a selective M2 muscarinic antagonist, SCH 72788 2001 ·Life Sciences ·Jean E. Lachowicz,Ruth A. Duffy,Vilma Ruperto,Joseph A. Kozlowski,Guowei Zhou,John W. Clader,William Billard,Herbert Binch,Gordon Crosby,Mary Cohen-Williams,Catherine D. Strader,(unknown)	32
18	Benzylidene ketal derivatives as M2 muscarinic receptor antagonists 2000 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Samuel Chackalamannil,(unknown),Sundeep Dugar,(unknown),William Billard,Herbert Binch,Gordon Crosby,Mary Cohen-Williams,Vicki L. Coffin,Ruth A. Duffy,Vilma Ruperto,Jean E. Lachowicz	8
19	Cholinergic improvement of a naturally-occurring memory deficit in the young rat 1996 ·Brain Research ·(unknown),(unknown),Mary Cohen-Williams,Vicki L. Coffin	39
20	Selective antagonism of the anticonvulsant effects of felbamate by glycine 1994 ·European Journal of Pharmacology ·Vicki L. Coffin,Mary Cohen-Williams,Allen Barnett	27

About Mary Cohen-Williams

Mary Cohen-Williams is a scholar working on Physiology, Cellular and Molecular Neuroscience and Biological Psychiatry, having authored 28 papers that have together received 892 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (11 papers), Neuroscience and Neuropharmacology Research (7 papers) and Adenosine and Purinergic Signaling (7 papers). The work is most often cited by research in Physiology (153 citations), Cellular and Molecular Neuroscience (445 citations) and Endocrine and Autonomic Systems (79 citations). Mary Cohen-Williams has collaborated with scholars based in United States, Bulgaria and Switzerland. Frequent co-authors include Geoffrey B. Varty, Vicki L. Coffin, John C. Hunter, Galen Carey, Jean E. Lachowicz, Robert A. Hodgson, Guy A. Higgins, Timothy J. Kowalski, Constance Farley and Brian D. Spar. Their work appears in journals such as Brain Research, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact